WHO Drug Information Vol. 14, No. 1, 2000: International Nonproprietary Names for Pharmaceutical Substances (INN): Recommended International Nonproprietary Names (Rec. INN): List 43

WHO Drug Information Vol. 14, No. 1, 2000
(2000; 81 pages)

Table of Contents

	General Policy Issues
		The benefits and risks of self-medication*
	Personal Perspectives
		Tobacco product regulation: what can be achieved?
	Reports on Individual Drugs
		Spread of quinolone-resistant salmonella
		Evidence for the role of zinc in childhood survival
		Increased risk of gastrointestinal bleeding: SSRIs and NSAIDs
		Clozapine and venous thromboembolism
		ACE inhibitors improve cardiovascular outcome
		Ticlopidine and thrombotic thrombocytopenic purpura
		Miltefosine: effectiveness in visceral leishmaniasis explored
	Current Topics
		HIV treatment guidelines for adults and adolescents
	Vaccines and Biomedicines
		Immunization safety: a global priority
		Cost effectiveness of influenza vaccination in healthy infants
		Diphtheria and tetanus vaccines: harmonization of testing in sight?
	General Information
		WHO Guidelines for the regulatory assessment of medicinal products for use in self-medication*
	Regulatory and Safety Matters
		Troglitazone withdrawn
		Cisapride and cardiac effects
		Cisapride: changes to labelling
		Cisapride: updated warning issued
		St John's wort: recommendations for use
		Northern hemisphere influenza vaccine
		Nicotine replacement therapy
		Anorectic agents: suspension of marketing authorization
		Insulin cartridges: leakage risk
		Zimox®: trade name duplication and risk of errors
		Benzbromarone and hepatitis
		Nevirapine: severe cutaneous reactions
		FDA cannot regulate tobacco industry
		New Internet website: information for consumers
		Cyber warnings for drug sales via the Internet
		Triax®: a harmful product sold on the Internet
		Illegal products on the market
		Epoetin alfa: inappropriate practices compromise product sterility
		Propylene glycol and amprenavir
		Trastuzumab: pulmonary reactions
	ATC/DDD Classification
		Temporary list
		Final list
	Recent Publications and Documents
		International Travel and Health
		WHO Expert Committee on Drug Dependence
		Correct handling and distribution of propylene glycol
		Reporting adverse drug reactions
		Preparing core safety information
		Good pharmaceutical procurement
	International Nonproprietary Names for Pharmaceutical Substances (INN)
		Recommended International Nonproprietary Names (Rec. INN): List 43
		Dénominations communes internationales des Substances pharmaceutiques (DCI)
		Denominaciones Comunes Internacionales para las Sustancias Farmacéuticas (DCI)
	Selected WHO Publications of Related Interest

Recommended International Nonproprietary Names (Rec. INN): List 43

Notice is hereby given that, in accordance with paragraph 7 of the Procedure for the Selection of Recommended International Nonproprietary Names for Pharmaceutical Substances [Off. Rec. Wld Health Org., 1955, 60, 3 (Resolution EB15.R7); 1969,173,10 (Resolution EB43.R9)], the following names are selected as Recommended International Nonproprietary Names. The inclusion of a name in the lists of Recommended International Nonproprietary Names does not imply any recommendation of the use of the substance in medicine or pharmacy. Lists of Proposed (1-73) and Recommended (1-35) International Nonproprietary Names can be found in Cumulative List No. 9, 1996.